Resumen:
Background: Maternal undernutrition programs fetal energy homeostasis and increases the risk of metabolic
disorders later in life. This study aimed to identify the signs of hepatic metabolic programming in utero and during
the juvenile phase after intrauterine undernutrition during midgestation.
Methods: Fifty-three pregnant goats were assigned to the control (100% of the maintenance requirement) or restricted
(60% of the maintenance requirement from day 45 to day 100 of midgestation and realimentation thereafter) group to
compare hepatic energy metabolism in the fetuses (day 100 of gestation) and kids (postnatal day 90).
Results: Undernutrition increased the glucagon concentration and hepatic hexokinase activity, decreased the body
weight, liver weight and hepatic expression of G6PC, G6PD,andPGC1α mRNAs,andtendedtodecreasethehepatic
glycogen content and ACOX1 mRNA level in the dams. Maternal undernutrition decreased the growth hormone (GH) and
triglyceride concentrations, tended to decrease the body weight and hepatic hexokinase activity, increased the hepatic
PCK1, PCK2 and PRKAA2 mRNAs levels and glucose-6-phosphatase activity, and tended to increase the hepatic PRKAB1
and CPT1α mRNAs levels in the male fetuses. In the restricted female fetuses, the hepatic hexokinase activity and G6PC
mRNA level tended to be increased, but PKB1 mRNA expression was decreased and the ACACA, CPT1α, NR1H3 and STK11
mRNA levels tended to be decreased. Maternal undernutrition changed the hepatic metabolic profile and affected the
metabolic pathway involved in amino acid, glycerophospholipid, bile acid, purine, and saccharide metabolism in the
fetuses, but not the kids. Additionally, maternal undernutrition increased the concentrations of GH and cortisol, elevated
the hepatic glucose-6-phosphate dehydrogenase activity, and tended to decrease the hepatic glycogen content in the
male kids. No alterations in these variables were observed in the female kids.
Conclusions: Maternal under nutrition affects the metabolic status in a sex- and stage-specific manner by changing the
metabolic profile, expression of genes involved in glucose homeostasis and enzyme activities in the liver of the fetuses.